Financial Consulate’s Thermo Fisher Scientific TMO Stock Holding History

Financial Consulate’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.9K	Sell	73 -577	-89%	-$313K	﹤0.01%	380
2025 Q4	$376K	Sell	650 -165	-20%	-$93.3K	0.05%	104
2025 Q3	$395K	Buy	+815	New	+$379K	0.06%	107
2023 Q2	–	Sell	-951	Closed	-$548K	–	106
2023 Q1	$548K	Buy	951 +33	+4%	+$18.6K	0.19%	60
2022 Q4	$506K	Buy	918 +24	+3%	+$12.7K	0.18%	69
2022 Q3	$453K	Buy	894 +29	+3%	+$16.2K	0.19%	62
2022 Q2	$470K	Sell	865 -37	-4%	-$20.4K	0.22%	64
2022 Q1	$533K	Buy	902 +24	+3%	+$13.8K	0.2%	63
2021 Q4	$586K	Sell	878 -10	-1%	-$6.24K	0.2%	60
2021 Q3	$507K	Buy	888 +99	+13%	+$54.3K	0.18%	61
2021 Q2	$398K	Buy	789 +101	+15%	+$47.7K	0.14%	74
2021 Q1	$314K	Buy	688 +130	+23%	+$62K	0.13%	82
2020 Q4	$260K	Buy	+558	New	+$262K	0.11%	87

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Consulate's TMO Position: Q1 2026 in Review

Financial Consulate reduced its Thermo Fisher Scientific (TMO) stake by 89% in Q1 2026, selling an estimated $313K and leaving 73 shares worth $35.9K. The position accounts for ﹤0.01% of the portfolio, ranked #380.

Financial Consulate first reported a position in TMO in Q4 2020 and has held it in 13 quarters since. The position peaked at $586K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Financial Consulate held 73 shares of Thermo Fisher Scientific worth $35.9K as of Q1 2026.
Financial Consulate sold 577 Thermo Fisher Scientific shares in Q1 2026, an estimated $313K.
Thermo Fisher Scientific made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #380 holding.
Financial Consulate first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 13 quarters since.
Financial Consulate's Thermo Fisher Scientific position peaked at $586K in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.